Patent: 6,201,105
✉ Email this page to a colleague
Summary for Patent: 6,201,105
Title: | Tumor necrosis factor receptor polypeptides recombinant P75 (Type II) |
Abstract: | Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed. |
Inventor(s): | Smith; Craig A. (Seattle, WA), Goodwin; Raymond G. (Seattle, WA), Beckmann; M. Patricia (Poulsbo, WA) |
Assignee: | |
Application Number: | 09/233,461 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,201,105 |
Patent Claims: | see list of patent claims |
Details for Patent 6,201,105
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | November 02, 1998 | ⤷ Sign Up | 2009-09-05 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | May 27, 1999 | ⤷ Sign Up | 2009-09-05 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | September 27, 2004 | ⤷ Sign Up | 2009-09-05 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | February 01, 2007 | ⤷ Sign Up | 2009-09-05 |
Immunex Corporation | ENBREL MINI | etanercept | Injection | 103795 | September 14, 2017 | ⤷ Sign Up | 2009-09-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,201,105
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 907072 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 9406476 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 9319777 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 9103553 | ⤷ Sign Up |
United States of America | RE36755 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |